TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26476489

Group type: EXPERIMENTAL
Intervention: lithium plus optimized personalized treatment (OPT)
Number of subjects: 283

Group type: COMPARATOR
Intervention: optimized personalized treatment (OPT) without lithium
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: 7‐item CHRT‐SR
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: 12‐item CHRT‐SR
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: CHRT‐SR scores
Number of subjects: 283
Study: 23503546

Group type: EXPERIMENTAL
Intervention: Nicotine patch application followed by oral levodopa/benserazide, 100/25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine and cotinine at 0.1 μmol/L
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 22167439

Group type: EXPERIMENTAL
Intervention: PepGen P-15 Putty
Number of subjects: 24
Study: 19339089

Group type: EXPERIMENTAL
Intervention: Vaccination with a standard trivalent inactivated influenza vaccine
Number of subjects: 201
Study: 16977443

Group type: EXPERIMENTAL
Intervention: Diffusion-weighted MR imaging (DWI) using navigated, interleaved, multishot echo planar imaging (IEPI)
Number of subjects: 6
Study: 15521371

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate and salmeterol (100 microg and 50 microg respectively)
Number of subjects: 267
Study: 11180571

Group type: EXPERIMENTAL
Intervention: Economic n-of-1 trials
Number of subjects: 0
Study: 9628086

Group type: EXPERIMENTAL
Intervention: Intravenous clonidine (1.3 micrograms/kg)
Number of subjects: 24
Study: 8791967

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg daily
Number of subjects: 118
Study: 2073024

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 6989171

Group type: EXPERIMENTAL
Intervention: 1 alpha‐OHD3 (1 microgram/day) + 2.5 g CaCO3
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31638680

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 400

Group type: COMPARATOR
Intervention: LEEP
Number of subjects: 400
Study: 28328862

Group type: EXPERIMENTAL
Intervention: levobupivacaine
Number of subjects: 62

Group type: COMPARATOR
Intervention: ropivacaine
Number of subjects: 62
Study: 26424587

Group type: EXPERIMENTAL
Intervention: 1 mg melatonin
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 1 mg melatonin (in women with sleep disturbances)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin (in women with sleep disturbances)
Number of subjects: 81
Study: 24384420

Group type: EXPERIMENTAL
Intervention: Heliox (He/O2=70%/30%)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol sulfate and budesonide administered by inhalation twice a day for 7 days with Heliox
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (N2/O2=70%/30%)
Number of subjects: 23
Study: 22197292

Group type: EXPERIMENTAL
Intervention: SHEWA-B intervention
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1000

Group type: COMPARATOR
Intervention: SHEWA-B intervention and Control group
Number of subjects: 1000
Study: 20175042

Group type: EXPERIMENTAL
Intervention: Moderately preterm birth (MPTB)
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Late preterm birth (LPTB)
Number of subjects: 552

Group type: COMPARATOR
Intervention: Term birth
Number of subjects: 552
Study: 18612885

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (8 sessions)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Twelve-step treatment (8 sessions)
Number of subjects: 126
Study: 16018918

Group type: EXPERIMENTAL
Intervention: Corticosteroid injections
Number of subjects: 109

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 109

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 109
Study: 12117401

Group type: EXPERIMENTAL
Intervention: Underpowered clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis of small studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small trials for rare diseases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early-phase trials for drug/device development
Number of subjects: 0
Study: 10721069

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (epileptics with comparable clinical characteristics and treatment)
Number of subjects: 16
Study: 8628336

Group type: EXPERIMENTAL
Intervention: Polyprenoic acid (600 mg daily)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Polyprenoic acid
Number of subjects: 89
Study: 1735251

Group type: EXPERIMENTAL
Intervention: Arm Elevation (AE) for 2 min
Number of subjects: 22

Group type: COMPARATOR
Intervention: Arm Lowering (AD) for 2 min
Number of subjects: 22
Study: 6398724

Group type: EXPERIMENTAL
Intervention: Maximum perineal stimulation (MPS) using monophasic square wave pulses under anaesthesia
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (no MPS)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Both groups (treatment and control)
Number of subjects: 107
Study: 31119695

Group type: EXPERIMENTAL
Intervention: Nasal dilator strip applied at bedtime for 28 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nasal dilator strip applied during nasal resistance phase (n=37)
Number of subjects: 70
Study: 28762058

Group type: EXPERIMENTAL
Intervention: Laparoscopic common bile duct exploration
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Open common bile duct exploration
Number of subjects: 210

Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiopancreatography
Number of subjects: 210
Study: 26513008

Group type: EXPERIMENTAL
Intervention: MM‐HIIT
Number of subjects: 28

Group type: COMPARATOR
Intervention: Row‐HIIT
Number of subjects: 28
Study: 23606339

Group type: EXPERIMENTAL
Intervention: Resistance exercise (6 exercises, 3 sets, 20 repetitions at 40-50% of 1RM)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (40 min of rest)
Number of subjects: 44
Study: 21556366

Group type: EXPERIMENTAL
Intervention: Epirubicin 90 mg/m²
Number of subjects: 223

Group type: COMPARATOR
Intervention: Paclitaxel 200 mg/m²
Number of subjects: 223
Study: 18236144

Group type: EXPERIMENTAL
Intervention: Large mug book
Number of subjects: 0

Group type: COMPARATOR
Intervention: Small mug book
Number of subjects: 0

Group type: COMPARATOR
Intervention: No mug book
Number of subjects: 0
Study: 18193118

Group type: EXPERIMENTAL
Intervention: PEG 4000 (Forlax)
Number of subjects: 100

Group type: COMPARATOR
Intervention: PEG 3350 (Movicolon)
Number of subjects: 100
Study: 15039009

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPh)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11227034

Group type: EXPERIMENTAL
Intervention: Infant formula with enzymatic degradation of phytic acid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Infant formula with native phytic acid content (Fe:ascorbic acid ratio 1:2.1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Infant formula with native phytic acid content (Fe:ascorbic acid ratio 1:4.2)
Number of subjects: 10
Study: 8403307

Group type: EXPERIMENTAL
Intervention: Losartan 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan 75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan 150 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan (all doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3948045

Group type: EXPERIMENTAL
Intervention: Fentanyl-oxygen (fentanyl-O2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Fentanyl-nitrous oxide/oxygen (fentanyl-N2O/O2)
Number of subjects: 14
Study: 28547924

Group type: EXPERIMENTAL
Intervention: 4-mm thin individually customized insole (CI-Core®) with synthetic textile material on the upper side
Number of subjects: 21

Group type: COMPARATOR
Intervention: No insoles
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 4-mm thin individually customized insole (CI-Core®)
Number of subjects: 21
Study: 26955605

Group type: EXPERIMENTAL
Intervention: Pomegranate peel extract (PPE) mouthrinse
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine mouthrinse
Number of subjects: 50
Study: 25271180

Group type: EXPERIMENTAL
Intervention: Child Life (CL)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Hospital Clowning (HC)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control
Number of subjects: 113
Study: 23545917

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate foam, 0.05%
Number of subjects: 125

Group type: COMPARATOR
Intervention: Vehicle foam
Number of subjects: 125
Study: 20878622

Group type: EXPERIMENTAL
Intervention: Plasma OPN
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Serum OPN
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (healthy subjects and BRD patients)
Number of subjects: 239
Study: 18251598

Group type: EXPERIMENTAL
Intervention: Microabrasion with 50 microm of aluminum silicate for 5 seconds followed by bonding with Scotchbond Multipurpose Plus Bonding Adhesive
Number of subjects: 52

Group type: COMPARATOR
Intervention: Bonding without microabrasion using the same bonding protocol
Number of subjects: 52
Study: 17091571

Group type: EXPERIMENTAL
Intervention: Hot tonsillectomy techniques (including diathermy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional cold-steel dissection with packs or ties
Number of subjects: 0
Study: 14520444

Group type: EXPERIMENTAL
Intervention: Cisplatin-gemcitabine (CG)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Epirubicin-gemcitabine (EG)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (CG)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL)
Number of subjects: 240
Study: 11881693

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo oralet
Number of subjects: 33
Study: 8694203

Group type: COMPARATOR
Intervention: Midazolam 0 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Midazolam 1 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Midazolam 2 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Midazolam 4 mg
Number of subjects: 80
Study: 1597911

Group type: EXPERIMENTAL
Intervention: Prepaid care (capitated health plans)
Number of subjects: 739

Group type: COMPARATOR
Intervention: Fee-for-service care
Number of subjects: 739
Study: 3758361

Group type: EXPERIMENTAL
Intervention: Intra-operative radiotherapy (IOR) with doses of 28 to 35 Gy using electron beams
Number of subjects: 101

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 101
Study: 31070113

Group type: EXPERIMENTAL
Intervention: Running speed measured at three different positions (Fo, Ti, Lu) on a treadmill at speeds between 8 and 18 km/h.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Measurement at the L4‐L5 lumbar (Lu) position.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Measurement at the centre of gravity of the tibia (Ti) position.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Measurement on the dorsal surface of the right foot (Fo) position.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Impact zone measurement points.
Number of subjects: 18
Study: 29481324

Group type: EXPERIMENTAL
Intervention: Anodal Electrical Stimulation (AG)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Cathodal Electrical Stimulation (CG)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo (PG)
Number of subjects: 61
Study: 27644589

Group type: EXPERIMENTAL
Intervention: Ranibizumab plus prompt laser treatment
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Ranibizumab plus deferred laser treatment
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Ranibizumab ± laser therapy
Number of subjects: 340
Study: 23967839

Group type: EXPERIMENTAL
Intervention: Dietary counselling for mothers during the first year of life
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 307
Study: 24236174

Group type: EXPERIMENTAL
Intervention: High Intensity-Interval Training (HIT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moderate Intensity-Continuous Training (MCT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: HIT and MCT
Number of subjects: 30
Study: 21477691

Group type: EXPERIMENTAL
Intervention: 90-mm Reddy female condom in Los Angeles
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 90-mm Reddy female condom in Pune
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (150 mm and 120 mm condoms)
Number of subjects: 50
Study: 19654255

Group type: COMPARATOR
Intervention: 2 percent lidocaine with 1:100,000 epinephrine (L100)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.5 percent bupivacaine with 1:200,000 epinephrine (B200)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 4 percent prilocaine with 1:200,000 epinephrine (P200)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 4 percent articaine with 1:200,000 epinephrine (A200)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3 percent mepivacaine without vasoconstrictor (Mw/o)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 4 percent articaine with 1:100,000 epinephrine (A100)
Number of subjects: 18
Study: 16723360

Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Systemic corticosteroid and/or immunosuppressive treatment
Number of subjects: 23
Study: 15319022

Group type: EXPERIMENTAL
Intervention: Olanzapine (1.25-2.5 mg/day starting dose, titrated to a mean of 14.5 mg/day by trial end)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Olanzapine (treatment group)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (during 2-week run-in phase)
Number of subjects: 10
Study: 11148857

Group type: EXPERIMENTAL
Intervention: Tilidine/naloxone solution (25 mg, 50 mg, 100 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Tilidine/naloxone solution (4 x 50 mg tilidine)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tilidine/naloxone retard tablets (50 mg, 100 mg, 200 mg tilidine/tablet)
Number of subjects: 18
Study: 9489119

Group type: EXPERIMENTAL
Intervention: Talc slurry (5 g in 50 mL saline)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Bleomycin (1 mg/kg in 50 mL saline)
Number of subjects: 26
Study: 8405501

Group type: EXPERIMENTAL
Intervention: Enoxaparin (ENX) 4200 anti factor Xa IU once daily
Number of subjects: 233

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) 7500 IU twice daily
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Overall incidence of PDVT after aortic surgery
Number of subjects: 233
Study: 3543577

Group type: EXPERIMENTAL
Intervention: Low dose heparin-DHE
Number of subjects: 259
Study: 30092205

Group type: EXPERIMENTAL
Intervention: Trigger point (TrP) release massage
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham ultrasound (US) treatment
Number of subjects: 25
Study: 28002415

Group type: EXPERIMENTAL
Intervention: Puberty education alone
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Reusable sanitary pads alone
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Puberty education and reusable sanitary pads
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1124
Study: 24191286

Group type: EXPERIMENTAL
Intervention: Low-dose angiotensin II infusion (1 ng/kg per minute) and captopril administration (25 mg×1)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: High-dose angiotensin II infusion (3 ng/kg per minute)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Aldosterone infusion (0.7 µg/kg per hour)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Spironolactone (50 mg/daily) for 6 weeks
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 23034336

Group type: EXPERIMENTAL
Intervention: Proclear multifocal toric contact lens (CL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Proclear toric single vision distance CL (DCL) combined with reading spectacles
Number of subjects: 20
Study: 20376430

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propofol (PRO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Difference in change of ACE score between DEX versus PRO
Number of subjects: 30
Study: 18568185

Group type: EXPERIMENTAL
Intervention: Low-dose indapamide (1.5 mg sustained release daily) with added perindopril
Number of subjects: 73
Study: 16380704

Group type: EXPERIMENTAL
Intervention: Serum ghrelin levels in MS patients (n=40)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy individuals, n=20)
Number of subjects: 40
Study: 12435173

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (Aranesp) at doses < 1.5 microg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (Aranesp) at doses 1.5 to 2.25 microg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (Aranesp) at doses > 2.25 microg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10612884

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including video scenarios and discussions coordinated by health personnel, aimed at promoting consistent condom use.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 8942774

Group type: EXPERIMENTAL
Intervention: Screening with faecal-occult-blood tests every 2 years for 10 years
Number of subjects: 137485

Group type: COMPARATOR
Intervention: Control group (unscreened)
Number of subjects: 137485

Group type: EXPERIMENTAL
Intervention: Screening group
Number of subjects: 137485

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 137485
Study: 1826911

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5, 5, 7.5, or 10 mg BID)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 7059544

Group type: EXPERIMENTAL
Intervention: Immediate amniotomy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Retaining membranes intact until full dilatation
Number of subjects: 68
Study: 31831388

Group type: EXPERIMENTAL
Intervention: Endovascular therapy plus standard medical therapy
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard medical therapy alone
Number of subjects: 131
Study: 31093922

Group type: EXPERIMENTAL
Intervention: Compression Stockings (CS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No Compression Stockings (Control)
Number of subjects: 20
Study: 27625142

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 1453
Study: 25808577

Group type: EXPERIMENTAL
Intervention: Occupational therapy plus repeated botulinum toxin A (BoNT‐A/OT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Occupational therapy alone
Number of subjects: 20
Study: 24269485

Group type: EXPERIMENTAL
Intervention: Tizanidine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 22970914

Group type: EXPERIMENTAL
Intervention: bFGF treatment (direct application of bFGF drops in the clinic and repeated daily by the patient, n = 53)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (spontaneous healing, n = 51)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: bFGF treatment (n = 53)
Number of subjects: 104
Study: 19176965

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 3,000 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16688629

Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 255

Group type: COMPARATOR
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 255
Study: 15560807

Group type: EXPERIMENTAL
Intervention: SRP and metronidazole (400 mg t.i.d. for 10 days)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: SRP and weekly professional supragingival plaque removal for three months (PC)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: SRP, metronidazole, and professional cleaning (PC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: SRP and placebo
Number of subjects: 44
Study: 11159875

Group type: EXPERIMENTAL
Intervention: 2 mg PRU
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 4 mg PRU
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9228354

Group type: EXPERIMENTAL
Intervention: BDP 84 (336 microg/d)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: BDP 42 (336 microg/d)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: HD BDP 84 (1,344 microg/d)
Number of subjects: 423
Study: 8427323

Group type: EXPERIMENTAL
Intervention: Experimental Group (E)
Number of subjects: 814

Group type: COMPARATOR
Intervention: Control Group (C)
Number of subjects: 814

Group type: COMPARATOR
Intervention: Historical Comparison Group (C)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: Cost-benefit analysis
Number of subjects: 814
Study: 2884895

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.5 microgram/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sufentanil 1 microgram/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no sufentanil)
Number of subjects: 0
Study: 29654645

Group type: EXPERIMENTAL
Intervention: Testosterone (100 mg testosterone enanthate weekly for 7 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 28